Pargeverine or pargeverine hydrochloride

General description Anti-PAR1 (Cleaved-Ser 42 ) Antibody detects endogenous levels of fragment of activated PAR1 (Cleaved-Ser 42 ) protein. Protease-activated receptor-1 (PAR1), also known as coagulation factor II thrombin receptor (F2R), is

General description Proteinase-activated receptor 4 (UniProt Q96RI0: also known as Coagulation factor II receptor-like 3, PAR-4, Thrombin receptor-like 3) is encoded by the F2RL3 (also known as PAR4) gene (Gene ID 9002) in human.

Immunogen Synthetic peptide directed towards the N terminal of human PARN Biochem/physiol Actions PARN is an oligomeric, processive, and cap-interacting 3&#8242: exonuclease. Sequence Synthetic peptide located within the following region:

General description PARS2 catalyzes the attachment of proline to tRNA(Pro) in a two-step reaction: proline is first activated by ATP to form Pro-AMP and then transferred to the acceptor end of tRNA(Pro). Immunogen PARS2 (NP_689481, 172-205) This

Anti-PARVA parvin, alpha, 25ul UN 1687 6.1 PG2

A potent inhibitor of PARPs, inhibiting PARP1 with an IC₅₀ value of 40 nM about 10-fold less potent against PARP2.

A potent inhibitor of PARPs, inhibiting PARP1 with an IC₅₀ value of 40 nM about 10-fold less potent against PARP2.

PAR

A cell-permeable isoquinolinedione compound that potently inhibits PARP-1 activity (pIC 50 = 7.35 IC 50 = 45 nM) in a NAD + -competitive and reversible manner, while affecting PPAR-2 activity with a 100-fold lower potency.

A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP1 (IC₅₀s = 0.3 and 8 &microM, respectively).

A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP1 (IC₅₀s = 0.3 and 8 &microM, respectively).

VEGENTINE FAST BROWN B